Variant ID | 31557 |
---|---|
Entrez Gene ID | 58508 |
Gene | MLL3 (GeneCards) |
Location | hg19 7:152008893-152008893
hg38 7:152311808-152311808 |
Disease | Asymptomatic |
Method | NGS gene panel |
Mutation(HGVS format) | NC_000007.13:g.152008893 A>- (Genome Assembly: hg19) |
Exon or Intron | NA |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 159138663 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
Deleterious probability by DeFine | 0.9444 (Deleterious) |
Entrez Gene ID | 58508 (NCBI Gene) |
---|---|
Official Gene Symbol | MLL3 (GeneCards) |
Number of variants in KMT2C in this database | 52 (view all the variants) |
Full name | lysine methyltransferase 2C |
Band | 7q36.1 |
Other IDs | Vega: OTTHUMG00000150553 OMIM: 606833 HGNC: HGNC:13726 Ensembl: ENSG00000055609 |
Other names | HALR, MLL3, KLEFS2 |
Summary | This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008] |
Individual ID | 25999502.02 (view all the variants in this individual) |
---|---|
Pubmed ID | 25999502 |
Whose mosaic mutation | Normal |
Origin of mosaic mutation in patients | de novo |
Phenotype | 1 |
Disease | Asymptomatic |
OMIM ID |
Pubmed ID | 25999502 |
---|---|
Title | High burden and pervasive positive selection of somatic mutations in normal human skin |
Journal | Science |
Publication date | 2015.05 |
Disease | Asymptomatic |
Number of cases | Male cases: 1; Female cases: 3; |